Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial-Reference-Cited by-同舟云学术

Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial

Published:2020-10-19 Issue: Volume: Page:1-3
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

de Sousa Vando Barbosa¹^ORCID,Arcanjo Francisco Placido¹,Aguiar Fernando²,Vasconcelos Jaqueline³,Oliveira Antonio Flavio¹,Honório Aline⁴,Pontes Juliana⁴

Affiliation:

1. Post-Graduation Program in Health Sciences, Universidade Federal do Ceará, Sobral, Brazil;

2. Department of Medicine, Universidade Federal do Piauí, Parnaíba, Brazil;

3. Departmant of Dermatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil;

4. Department of Medicine, Centro Universitário INTA, Sobral, Brazil

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2020.1788703

Reference11 articles.

1. Alopecia areata

2. Alopecia areata

3. Intralesional betamethasone as a therapeutic option for alopecia areata

4. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases

5. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alopecia Areata: An Updated Review for 2023;Journal of Cutaneous Medicine and Surgery;2023-05

2. The optimal concentration of intralesional triamcinolone acetonide for patchy alopecia areata: A systematic review and meta-analysis;Dermatologica Sinica;2022

3. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management;Clinical Reviews in Allergy & Immunology;2021-08-17